Search ( 33944 results )
- article
(Updated on )
Evaluation of Organized Breast Cancer Screening in France in 2000
The national organized breast cancer screening program for women aged 50 to 69 was launched in 1994 following a pilot phase (1989–1991) conducted in 10 departments. The evaluation of...
(Updated on )
Pleural mesothelioma
Given the particular importance of estimating the number of new cases of pleural mesothelioma for public health in France, a national mesothelioma surveillance program (PNSM) was...
- article
(Updated on )
Awareness of Diabetes in France: Initial Findings from the Entred Study
- report/summary
(Updated on )
HIV Screening and Diagnosis in Laboratories: LaboVIH 2001–2003
One year after the implementation, in early 2003, of mandatory reporting of HIV infection diagnoses, the number of new HIV diagnoses is estimated at approximately 6,000 in 2003. This...
- report/summary
(Updated on )
HIV Virological Surveillance. Data as of March 31, 2004
One year after the implementation, in early 2003, of mandatory reporting of HIV infection diagnoses, the number of new HIV diagnoses is estimated at approximately 6,000 in 2003. This...
- report/summary
(Updated on )
Mandatory reporting of AIDS in France. Data as of March 31, 2004
One year after the implementation, in early 2003, of mandatory reporting of HIV infection diagnoses, the number of new HIV diagnoses is estimated at approximately 6,000 in 2003. This...
- report/summary
(Updated on )
Mandatory reporting of HIV infection. Data as of March 31, 2004
One year after the implementation, in early 2003, of mandatory reporting of HIV infection diagnoses, the number of new HIV diagnoses is estimated at approximately 6,000 in 2003. This...
- report/summary
(Updated on )
HIV/AIDS Surveillance in France. Data as of June 30, 2004
- report/summary
(Updated on )
HIV/AIDS Surveillance in France. Report No. 2. Data as of March 31, 2004
One year after the implementation, in early 2003, of mandatory reporting of HIV infection diagnoses, the number of new HIV diagnoses is estimated at approximately 6,000 in 2003. This...
- report/summary
(Updated on )
Estimates of the prevalence rates of anti-HCV antibodies and hepatitis B virus markers among individuals covered by the general social security system in metropolitan France, 2003–2004. Descriptive analysis, 2005
A prevalence survey of serum markers for hepatitis B (HBV) and C (HCV) infections was conducted from 2003 to 2004 using a national sample of individuals covered by the general health...
